Stock 301089 TUOXIN PHARMACEUTICAL GROUP CO.,LTD.
Add to a list
To use this feature you must be a member
Log inSign up

All News Tuoxin Pharmaceutical Group Co.,Ltd.

Equities

301089

CNE100004YC3

End-of-day quote Shenzhen S.E.
Other stock markets
 03:30:00 31/05/2024 am IST 		5-day change 1st Jan Change
34.85 CNY +0.11% Intraday chart for Tuoxin Pharmaceutical Group Co.,Ltd. -4.28% -35.47%
14/05 Tuoxin Pharmaceutical Group Co.,Ltd. Approves 2023 Profit Distribution Plan CI
14/05 Tuoxin Pharmaceutical Group Co.,Ltd. Elects Lin Xiansheng and Yang Shaohua as Non-Independent Directors CI

All News

Search
See the results
Unlock all the news: Be the first to know and act before the market!
100% Free Registration
Tuoxin Pharmaceutical Group Co.,Ltd. Approves 2023 Profit Distribution Plan
CI
Tuoxin Pharmaceutical Group Co.,Ltd. Elects Lin Xiansheng and Yang Shaohua as Non-Independent Directors
CI
Tuoxin Pharmaceutical Group Co.,Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024
CI
Tuoxin Pharmaceutical Group Co.,Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023
CI
Tuoxin Pharmaceutical Group Co.,Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2023
CI
Tuoxin Pharmaceutical Group Co.,Ltd.(XSEC:301089) added to S&P Global BMI Index
CI
Tuoxin Pharmaceutical Group Co.,Ltd. Reports Earnings Results for the Half Year Ended June 30, 2023
CI
Xinxiang Tuoxin Pharmaceutical Co.,Ltd. Approves the Cash Dividend for the Year 2022, Payment Date: 06 June 2023
CI
Xinxiang Tuoxin Pharmaceutical Co.,Ltd. has Changed its Name to Tuoxin Pharmaceutical Group Co., Ltd
CI
Xinxiang Tuoxin Pharmaceutical Co.,Ltd. Approves the Cash Dividend for the Year 2022
CI
Xinxiang Tuoxin Pharmaceutical Co.,Ltd. Proposes Final Cash Dividend for the Year of 2022
CI
Xinxiang Tuoxin Pharmaceutical Co.,Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023
CI
Xinxiang Tuoxin Pharmaceutical Co.,Ltd. Reports Earnings Results for the Full Year Ended December 31, 2022
CI
Xinxiang Tuoxin Pharma to Form New Chemical Products Subsidiary
MT
Xinxiang Tuoxin Pharmaceutical Co.,Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2022
CI
Xinxiang Tuoxin Pharmaceutical Co.,Ltd. Reports Earnings Results for the Half Year Ended June 30, 2022
CI
Xinxiang Tuoxin Pharmaceutical Co.,Ltd. Announces Final Cash Dividend on A Shares for the Year 2021, Payable on May 25, 2022
CI
Xinxiang Tuoxin Pharmaceutical Co.,Ltd. Approves Cash Dividend for 2021
CI
Tuoxin Pharmaceutical to Free Up 1.5 Million Shares For Trading; Shares Tank 5%
MT
Xinxiang Tuoxin Pharma’s 2021 Profit Plunges 42% as Sales Slip 5%
MT
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. 301089 Stock
  4. News Tuoxin Pharmaceutical Group Co.,Ltd.